A survey of 100 institutional investors conducted by business school EDHEC showed that only 15% have invested in replication products, with 30% reporting that they will never do so. The majority of respondents doubted that the behaviour of hedge funds could be replicated and criticized the products’ poor performance, lack of transparency and deficient technology.
